Escherichia coli vaccine (Middle East for Vaccines)

The Escherichia coli vaccine produced by Middle East for Vaccines (MEVAC) is a veterinary biologic indicated for the immunization of poultry against infections caused by pathogenic *Escherichia coli* (colibacillosis). The vaccine is designed to stimulate the bird's immune system to recognize and neutralize *E. coli* antigens, thereby reducing mortality, lesion severity, and economic losses associated with respiratory tract infections, septicemia, and cellulitis in broiler and breeder flocks. As an inactivated bacterial vaccine (bacterin), it typically contains killed pathogenic strains that induce a protective antibody response without the risk of causing disease.

Brand names

MEVAC E. COLI

Other names

Escherichia coli VaccineE. coli vaccine (Poultry)